Aligos Therapeutics Inc.

South San Francisco, CA Doing business as Aligos Therapeutics

UEI
ED19ABDRLV29
CAGE
96ED3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1 Corporate Dr 2Nd Floor, South San Francisco, CA 94080, USA
Website
aligos.com
Founded
2018
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Aligos Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
To conduct clinical development of a compound for the treatment of covid-19. Contract · 75N93023C00052 National Institute of Allergy and Infectious Diseases $11,286,393

SBA capabilities narrative

Aligos Therapeutics, Inc. is a clinical-stage

biopharmaceutical company founded with the mission to

improve patient outcomes by developing best-in-class

therapies for the treatment of liver and viral diseases.

Aligos applies its science driven approach and deep R&D

expertise to advance its purpose-built pipeline of

therapeutics for diseases with high unmet medical need

such as chronic hepatitis B infection (CHB), metabolic

dysfunction-associated steatohepatitis (MASH), and

coronaviruses.

Quick answers

What is Aligos Therapeutics Inc.'s UEI?

Aligos Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is ED19ABDRLV29.

What is Aligos Therapeutics Inc.'s CAGE code?

Aligos Therapeutics Inc.'s CAGE code is 96ED3.

What is Aligos Therapeutics Inc.'s primary NAICS code?

Aligos Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Aligos Therapeutics Inc. located?

Aligos Therapeutics Inc.'s physical address in SAM.gov is 1 Corporate Dr 2Nd Floor, South San Francisco, CA 94080, USA.

Is Aligos Therapeutics Inc. registered in SAM.gov?

Yes. Aligos Therapeutics Inc.'s SAM.gov registration is active through February 17, 2027.

What is Aligos Therapeutics Inc.'s most recent federal award?

Aligos Therapeutics Inc.'s most recent federal contract award is To conduct clinical development of a compound for the treatment of covid-19 (75N93023C00052), from National Institute of Allergy and Infectious Diseases, on September 22, 2023.

On GovTribe

See Aligos Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors